Tongxinbi formula attenuates post-MI cardiac injury through Keap1/Nrf2-mediated control of oxidative stress and inflammationOA
Tongxinbi formula attenuates post-MI cardiac injury through Keap1/Nrf2-mediated control of oxidative stress and inflammation
Zi-Jie Zhu;Jia Liu;Yu-Lan Qian;Chao Zhang;Shi-Hai Yan;Hua-Qin Tong;Dao-Cheng Wang
Department of Cardiology,Yangzhou Hospital Affiliated to Nanjing University of Chinese Medicine,Yangzhou 225009,ChinaDepartment of Cardiology,Yangzhou Hospital Affiliated to Nanjing University of Chinese Medicine,Yangzhou 225009,ChinaDepartment of Cardiology,Yangzhou Hospital Affiliated to Nanjing University of Chinese Medicine,Yangzhou 225009,ChinaDepartment of Cardiology,Yangzhou Hospital Affiliated to Nanjing University of Chinese Medicine,Yangzhou 225009,ChinaResearch Laboratory of Pharmacology of Traditional Chinese Medicine,The Affiliated Hospital of Nanjing University of Chinese Medicine,Nanjing 210029,ChinaDepartment of Cardiology,Yangzhou Hospital Affiliated to Nanjing University of Chinese Medicine,Yangzhou 225009,ChinaDepartment of Cardiology,Yangzhou Hospital Affiliated to Nanjing University of Chinese Medicine,Yangzhou 225009,China
myocardial infarctionoxidative stressKeap1/Nrf2 signaling pathwayendothelial dysfunction
myocardial infarctionoxidative stressKeap1/Nrf2 signaling pathwayendothelial dysfunction
《传统医学研究（英文版）》 2026 (4)
1-10,10
This investigation received research funding from the Major Special Project of Jiangsu Administration of Traditional Chinese Medicine(Project No.ZT202116),the Key R&D Project of Jiangsu Province(Project No.BE2020727),the Yangzhou Science and Technology Program(Project No.YZ2021062,YZ2024143 and YZ2024194),the Third Batch of Academic Mentorship Program for Senior TCM Experts in Jiangsu Province(Project No.2019028),and the 2023 Jiangsu Pharmaceutical Association-Aosaikang Hospital Pharmacy Research Project(Project No.A202333).
评论